More Information About - Lulizol Cream 10/gm Cream - 10gm
Description
Generic Name
Luliconazole 1% Topical
Precaution
For topical use only; not for ophthalmic or intravaginal administration
Lactation
There is no information available on presence in human milk, effects of drug on breastfed infant, or effects of drug on milk production after topical application to women who are breastfeeding;
Indication
Indicated for the topical treatment of, tinea corporis (ring worm), tinea cruris (jock itch), interdigital tinea pedis (athelet's foot)
Contra Indication
None
Dose
N/A
Side Effect
<1%
Application site reactions
Pregnancy Category
Name :
Not Classified
Description
FDA has not yet classified the drug into a specified pregnancy category.
Mode of Action
Imidazole antifungal that alters the fungal cell membrane; interacts with 14-alpha demethylase (an enzyme necessary for conversion of lanosterol to ergosterol), inhibiting the synthesis of ergosterol which is an essential component of the membrane; increases cell permeability causing leakage of cellular contents
Interaction
N/A
Pregnancy Category Note
Pregnancy
There are no available data with use in pregnant women to inform a drug-associated risk for major birth defects and miscarriage; in animal reproduction studies with pregnant rats and rabbits, there were no adverse developmental effects observed with subcutaneous administration of luliconazole during organogenesis at doses up to 3 and 24 times, respectively, the maximum recommended human dose (MRHD)
Lactation
There is no information available on presence in human milk, effects of drug on breastfed infant, or effects of drug on milk production after topical application to women who are breastfeeding; lack of clinical data during lactation precludes a clear determination of risk to an infant during lactation; developmental and health benefits of breastfeeding should be considered along with mother?s clinical need for therapy and any potential adverse effects on breastfed infant from therapy or from underlying maternal condition
Adult Dose
Topical cream
Adult:
Interdigital Tinea Pedis: Cream, 1% should be applied to the affected and immediate surrounding area(s) once a day for two weeks.
Tinea Cruris and Tinea Corporis: Cream, 1% should be applied to the affected skin and immediate surrounding area(s) once a day for one week.
Child Dose
Topical cream
Child:
Tinea Corporis, Tinea Cruris
<12 years: Safety and efficacy not established
12-18 years: Apply cream to affected area once a day for 1 week
Tinea Pedis
<2 years: Safety and efficacy not established
2-18 years: Apply cream to affected area once a day for 2 weeks
Renal Dose
N/A
Administration
Apply cream to the affected area and 1 inch surrounding area(s).
Disclaimer
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.